MED SIGMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MED SIGMA
Largest movements
- Cash +€261,472
up €261,472 (+99.3%), from €263,212 to €524,684
mainly Net result for the year (+€268,951) and Depreciation (+€5,596)
- Deferred charges and accrued income +€6,172
up €6,172 (+3159.8%), from €195 to €6,367
- Profit (loss) carried forward +€268,951
up €268,951 (+92.9%), from €289,419 to €558,370
- Tax, wage and social debts -€11,975
no longer reported in 2025 (was €11,975)
of which Taxes: -€7,198
- Gross operating margin -€35,257
down €35,257 (-9.0%), from €391,720 to €356,464
- Taxes -€8,065
down €8,065 (-8.7%), from €93,218 to €85,153
- Depreciation -€5,936
down €5,936 (-51.5%), from €11,532 to €5,596
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €306,468 | €566,884 | +€260,416 | +85.0% |
| Fixed assets | 21/28 | €6,968 | €2,718 | -€4,250 | -61.0% |
| Tangible fixed assets | 22/27 | €6,968 | €2,718 | -€4,250 | -61.0% |
| Furniture and vehicles | 24 | €6,968 | €2,718 | -€4,250 | -61.0% |
| Current assets | 29/58 | €299,500 | €564,166 | +€264,666 | +88.4% |
| Amounts receivable within one year | 40/41 | €36,093 | €33,115 | -€2,978 | -8.2% |
| Trade receivables | 40 | €36,093 | €32,957 | -€3,136 | -8.7% |
| Other amounts receivable | 41 | - | €158 | +€158 | |
| Cash at bank and in hand | 54/58 | €263,212 | €524,684 | +€261,472 | +99.3% |
| Deferred charges and accrued income | 490/1 | €195 | €6,367 | +€6,172 | +3159.8% |
| Total equity and liabilities | 10/49 | €306,468 | €566,884 | +€260,416 | +85.0% |
| Equity | 10/15 | €292,419 | €561,370 | +€268,951 | +92.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €289,419 | €558,370 | +€268,951 | +92.9% |
| Amounts payable | 17/49 | €14,049 | €5,514 | -€8,535 | -60.8% |
| Amounts payable within one year | 42/48 | €14,049 | €5,514 | -€8,535 | -60.8% |
| Trade debts | 44 | €405 | €716 | +€311 | +76.9% |
| Suppliers | 440/4 | €405 | €716 | +€311 | +76.9% |
| Taxes, remuneration and social security | 45 | €11,975 | - | -€11,975 | |
| Taxes | 450/3 | €7,198 | - | -€7,198 | |
| Remuneration and social security | 454/9 | €4,777 | - | -€4,777 | |
| Other amounts payable | 47/48 | €1,670 | €4,799 | +€3,129 | +187.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,532 | €5,596 | -€5,936 | -51.5% |
| Other operating charges | 640/8 | €708 | €1,074 | +€366 | +51.7% |
| Gross operating margin | 9900 | €391,720 | €356,464 | -€35,257 | -9.0% |
| Operating profit (loss) | 9901 | €379,481 | €349,794 | -€29,687 | -7.8% |
| Financial income | 75/76B | €3,414 | €4,370 | +€956 | +28.0% |
| Recurring financial income | 75 | €3,414 | €4,370 | +€956 | +28.0% |
| Financial charges | 65/66B | €258 | €60 | -€198 | -76.7% |
| Recurring financial charges | 65 | €258 | €60 | -€198 | -76.7% |
| Profit (loss) for the period before taxes | 9903 | €382,637 | €354,104 | -€28,533 | -7.5% |
| Income taxes | 67/77 | €93,218 | €85,153 | -€8,065 | -8.7% |
| Profit (loss) for the period | 9904 | €289,419 | €268,951 | -€20,468 | -7.1% |
| Profit (loss) for the period to be appropriated | 9905 | €289,419 | €268,951 | -€20,468 | -7.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.